Targeting α-synuclein for treatment of Parkinson’s disease: mechanistic and therapeutic considerations.

Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stéphane Hunot, Andrew Singleton, C Warren Olanow, Kalpana M Merchant, Erwan Bezard, Gregory A Petsko, Wassilios G Meissner
The Lancet Neurology. 2015-08-01; 14(8): 855-866
DOI: 10.1016/s1474-4422(15)00006-x

Read on PubMed

Know more about